Banet Natalie, Ning Yi, Montgomery Elizabeth A
Departments of Pathology (N.B.), Division of Gynecologic Pathology Division of Molecular Pathology (Y.N.) Division of Surgical Pathology (E.A.M.), The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland.
Int J Gynecol Pathol. 2015 Sep;34(5):419-23. doi: 10.1097/PGP.0000000000000175.
Inflammatory myofibroblastic tumor has been described in a wide variety of anatomic sites, although in the gynecologic tract, it has mostly been documented in the uterus, and has never been described in the placenta. Two patients presented with well-circumscribed placental masses that showed classic histologic features of inflammatory myofibroblastic tumor including a proliferation of myofibroblastic cells, a mixed inflammatory infiltrate, and a myxoid background. One case was positive by immunohistochemistry for anaplastic lymphoma kinase (ALK-1), whereas the other was negative by immunohistochemistry and fluorescent in situ hybridization. Inflammatory myofibroblastic tumors should be differentiated from other more aggressive uterine tumors that may involve the placenta by direct extension/metastasis because they can be managed conservatively, and in these 2 cases, did not seem to affect the course of the patient's pregnancies.
炎性肌纤维母细胞瘤已在多种解剖部位被描述,尽管在女性生殖道中,大多记录于子宫,而从未在胎盘中有过描述。两名患者出现边界清晰的胎盘肿物,其显示出炎性肌纤维母细胞瘤的典型组织学特征,包括肌纤维母细胞增殖、混合性炎性浸润及黏液样背景。1例经免疫组化检测间变性淋巴瘤激酶(ALK-1)呈阳性,而另1例免疫组化及荧光原位杂交均为阴性。炎性肌纤维母细胞瘤应与其他可能通过直接蔓延/转移累及胎盘的更具侵袭性的子宫肿瘤相鉴别,因为其可采用保守治疗,且在这2例中,似乎未影响患者的妊娠进程。